将翔一 (@makeikusaka) header
将翔一 (@makeikusaka) profile picture

四十代兼業投資家。オンコリス🐿 16年から保有開始 john sedivy Transposon Therapeutics Precision Virologics Unleash Immuno Oncolytic Domain Associates Team BBV154

Joined December 2016
Photo by 将翔一 (@makeikusaka)Photo by 将翔一 (@makeikusaka)Photo by 将翔一 (@makeikusaka)Photo by 将翔一 (@makeikusaka)Photo by 将翔一 (@makeikusaka)Photo by 将翔一 (@makeikusaka)Photo by 将翔一 (@makeikusaka)Photo by 将翔一 (@makeikusaka)Photo by 将翔一 (@makeikusaka)Photo by 将翔一 (@makeikusaka)
16かぁ
3
348
準備中 PI for a clinical trial sponsored by the Alzheimer’s Association, and is a site clinician for clinical trials sponsored by Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.
1
7
890
Importantly, drugs like lecanemab and donanemab are not cures for AD and there is no evidence to suggest that these agents halt or reverse cognitive impairment. 併用か
5
586
Alzheimer 期待
3
364
Oncolys USA, Inc.. Unfortunately, at this time, we do not have any job vacancies.
1
2
374
Happy days are here again!
3
261
GNIすばらしいですね。 こちらも少しの変化 transposonrx.com/
7
239
clinicaltrials.gov/ct2/histo… 7件でおわりか! オンコリ
3
1
12
2,478